Karen Manion

751 total citations
8 papers, 522 citations indexed

About

Karen Manion is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Karen Manion has authored 8 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Karen Manion's work include Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (3 papers) and Neutropenia and Cancer Infections (2 papers). Karen Manion is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (3 papers) and Neutropenia and Cancer Infections (2 papers). Karen Manion collaborates with scholars based in United States. Karen Manion's co-authors include Lawrence E. Morris, Asad Bashey, Scott R. Solomon, H. Kent Holland, Connie A. Sizemore, Stacey Brown, Xu Zhang, J Moreb, John R. Wingard and Helen Leather and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bone Marrow Transplantation.

In The Last Decade

Karen Manion

8 papers receiving 517 citations

Peers

Countries citing papers authored by Karen Manion

Since Specialization

Citations

This map shows the geographic impact of Karen Manion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Manion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Manion more than expected).

Fields of papers citing papers by Karen Manion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Manion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Manion. The network helps show where Karen Manion may publish in the future.

Co-authorship network of co-authors of Karen Manion

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Manion. A scholar is included among the top collaborators of Karen Manion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Manion. Karen Manion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation 2013 ·Journal of Clinical Oncology ·Asad Bashey, Xu Zhang, Connie A. Sizemore, Karen Manion, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Scott R. Solomon	333
2	T-Cell Replete Haploidentical Transplantation Using Post-Transplant Cyclophosphamide Results in Equivalent Non-Relapse Mortality and Disease-Free Survival Compared to Transplantation From HLA-Identical Sibling and Matched Unrelated Donors: A Stratified Cox Model Analysis of Two Hundred and Sixty Contemporaneous Allogeneic Transplants From a Single Center 2011 ·Blood ·Asad Bashey, Xu Zhang, Connie A. Sizemore, Karen Manion, Stacey Brown, H. Kent Holland, Scott R. Solomon, Lawrence E. Morris	6
3	Low Dose Subcutaneous Alemtuzumab and Preemptive Donor Lymphocyte Infusion without Withdrawal of Immunosuppression Results in Low Non-Relapse Mortality, Decreased Hospitalization, and Favorable Outcomes for High Risk Older Recipients of Unrelated Donor Allogeneic Transplants: A Prospective Phase II Trial 2011 ·Blood ·Connie A. Sizemore, Asad Bashey, Karen Manion, H. Kent Holland, Lawrence E. Morris, Stacey Brown, Xu Zhang, Scott R. Solomon	1
4	Haploidentical Transplantation Using T-Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors Is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of A Prospective Phase II Trial 2011 ·Blood ·Connie A. Sizemore, Asad Bashey, Melissa Sanacore, Karen Manion, H. Kent Holland, Lawrence E. Morris, Stacey Brown, Xu Zhang, Scott R. Solomon	8
5	Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM 2009 ·Bone Marrow Transplantation ·Scott R. Solomon, (unknown), (unknown), Asad Bashey, Karen Manion, (unknown), (unknown), (unknown), Lawrence E. Morris, H. Kent Holland	31
6	Cryopreserved G-CSF Mobilized Donor Lymphocyte Infusion (DLI) without Withdrawal of Immunosuppression Is Safe and Highly Effective for Treating Isolated Poor Donor T-cell Chimerism Following Reduced Intensity Allogeneic Transplantation (RICT). 2009 ·Blood ·Asad Bashey, Karen Manion, (unknown), (unknown), H. Kent Holland, Lawrence E. Morris, Scott R. Solomon	1
7	Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital 2002 ·Bone Marrow Transplantation ·(unknown), J Moreb, Dario R. Roque, Karen Manion, Helen Leather, Vijay Reddy, (unknown), (unknown), Nguyễn Hải Hà, (unknown), (unknown), John R. Wingard	138
8	Gvhd and cmv antigenemia after allogeneic peripheral blood stem cell transplantation: comparison between myeloablative and nonmyeloablative (mini) conditioning regimens. v 2000 ·Blood ·Bradley H Pollock, (unknown), (unknown), (unknown), Karen Manion, Dario R. Roque	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact